Analystreport

Protagonist Therapeutics Inc (NASDAQ: PTGX) had its price target raised by analysts at Nomura from $29.00 to $33.00. They now have a "buy" rating on the stock.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com